Unconfigured Ad
Collapse
Any topic/question that does not fit into the subcategories below. If you're unsure of where to put something, ask in here!
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by nilshomer, 05-08-2010, 02:19 PM
|
52 responses
118,258 views
0 reactions
|
Last Post
by archana87
04-23-2019, 01:18 PM
|
||
|
Started by Anke, 06-18-2015, 12:59 AM
|
0 responses
2,287 views
0 reactions
|
Last Post
by Anke
06-18-2015, 12:59 AM
|
||
|
Started by ecSeq Bioinformatics, 06-16-2015, 08:10 AM
|
0 responses
2,011 views
0 reactions
|
Last Post
|
||
|
Started by clueheart, 06-10-2015, 07:00 AM
|
4 responses
1,603 views
0 reactions
|
Last Post
|
||
|
Started by kaps, 06-10-2015, 12:33 AM
|
3 responses
1,732 views
0 reactions
|
Last Post
by GenoMax
06-10-2015, 03:04 AM
|
||
|
Started by newb, 06-10-2015, 01:13 AM
|
2 responses
1,334 views
0 reactions
|
Last Post
by newb
06-10-2015, 02:53 AM
|
||
|
Started by roshanbernard, 06-05-2015, 11:35 PM
|
1 response
2,633 views
0 reactions
|
Last Post
|
||
|
Started by seqador, 07-08-2014, 05:38 PM
|
10 responses
3,364 views
0 reactions
|
Last Post
by QazSeDc
06-04-2015, 09:53 PM
|
||
|
Started by GenoMax, 06-18-2012, 12:06 PM
|
17 responses
8,925 views
0 reactions
|
Last Post
by westerman
06-04-2015, 06:31 AM
|
||
|
Started by emilywabash, 06-03-2015, 12:00 AM
|
0 responses
974 views
0 reactions
|
Last Post
by emilywabash
06-03-2015, 12:00 AM
|
||
|
Started by kaps, 05-31-2015, 10:52 PM
|
4 responses
2,320 views
0 reactions
|
Last Post
by kaps
06-02-2015, 05:37 AM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 08-24-2026, 10:32 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
08-24-2026, 10:32 AM
|
||
|
Started by SEQadmin2, 08-20-2026, 11:17 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
08-20-2026, 11:17 AM
|
||
|
Started by SEQadmin2, 08-18-2026, 10:05 AM
|
0 responses
35 views
0 reactions
|
Last Post
by SEQadmin2
08-18-2026, 10:05 AM
|